Saturday 17 October 2026
Export ADIL’s income statement to Excel — free account
Adial Pharmaceuticals, Inc.
ADIL Healthcare Biotechnology
In the quarter to June 2026, EPS fell 150.0% and free cash flow fell 263.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
3.49
0.35
+11.15%
Follow ADIL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
4.42 | 4.16 | 4.90 | 2.67 | 2.37 | 3.41 | 14.23 | 18.19 | 0.03 | 0.55 |
Net Debt/EBITDA |
0.75 | 0.45 | 0.41 | 0.37 | 0.32 | 0.40 | 0.82 | 0.58 | 0.02 | 0.21 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.81 | 0.52 | 1.33 | 0.88 | 0.62 | 0.70 | 0.74 | 0.21 | 0.43 | 0.65 |
Capex/Depreciation |
250.00 | 0.00 | 0.00 | 0.00 | (1.17) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
— | — | — | (171.83) | (2,967.49) | (336.25) | (86.61) | (5.99) | (6.89) | (42.79) |
| (170.73%) | (323.80%) | (139.22%) | (375.32%) | (518.38%) | (195.80%) | (148.36%) | (675.52%) | 206.97% | 76.32% | |
| (136.16%) | (269.87%) | (97.87%) | (192.79%) | (299.59%) | (165.41%) | (138.81%) | (491.42%) | (1,225.27%) | (451.83%) | |
ROIC |
0.00% | (1,630.29%) | (342.64%) | 0.00% | 0.00% | 0.00% | (1,417.62%) | (763.06%) | 0.00% | 0.00% |
Return on Tangible Assets |
(166.75%) | (428.09%) | (201.26%) | (425.94%) | (511.50%) | (300.05%) | (120.42%) | (262.29%) | 113.39% | 369.89% |
Average Days of Receivables |
— | — | — | — | — | — | — | — | — | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.21 | 0.05 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(9.49) | (35.66) | (119.42) | (278.95) | (404.51) | (383.58) | (401.18) | (328.74) | (95.17) | (52.77) |
Cash per Share |
8.80 | 19.32 | 49.60 | 99.80 | 204.11 | 221.16 | 428.93 | 509.08 | 3.50 | 16.92 |
Shareholders Equity per Share |
7.89 | 20.96 | 71.64 | 81.71 | 118.11 | 200.31 | 451.94 | 584.38 | (191.85) | (19.90) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.89 | 20.96 | 71.64 | 81.71 | 118.11 | 200.31 | 451.94 | 584.38 | (191.85) | (19.90) |
Free Cash Flow |
(6.34) | (6.92) | (6.81) | (11.19) | (12.01) | (7.63) | (6.34) | (2.50) | (0.49) | (0.27) |
Working Capital |
4.78 | 3.08 | 2.55 | 2.99 | 3.74 | 3.63 | 7.13 | 4.43 | (1.00) | (0.11) |
Capital Expenditures |
0.15 | — | — | — | (0.06) | — | — | — | — | — |
Net Current Asset Value |
4.78 | 3.08 | 2.55 | 2.32 | 2.49 | 3.63 | 7.13 | 4.43 | (1.00) | (0.11) |
| Other line items | ||||||||||
Quick Ratio |
4.21 | 3.84 | 4.33 | 2.23 | 2.23 | 2.92 | 12.57 | 15.00 | 0.02 | 0.35 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(56.85%) | (88.54%) | (98.50%) | (153.69%) | (125.54%) | (91.01%) | (45.54%) | (30.06%) | 50.53% | 1,770.32% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(9.71) | (35.66) | (119.42) | (278.95) | (402.34) | (383.58) | (401.18) | (328.74) | (95.17) | (52.77) |
Capex per Share |
0.22 | 0.00 | 0.00 | 0.00 | (2.18) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
0.45 | 0.18 | 0.19 | 0.28 | 0.47 | 0.42 | 0.14 | 0.22 | 0.18 | 0.18 |
Average Assets |
5.86 | 4.89 | 5.23 | 6.60 | 6.48 | 6.59 | 6.19 | 2.37 | 0.09 | 0.09 |
Average Common Equity |
4.67 | 4.08 | 3.68 | 3.39 | 3.75 | 5.56 | 5.79 | 1.72 | (0.55) | (0.55) |
Capex to Sales |
0.00 | — | — | — | 0.00 | — | — | — | — | — |
Columns are period end dates